⚖️DEA Revocation Order Impacting Texas Veterinarian Registration
The Drug Enforcement Administration (DEA) has issued a final order revoking the registration of Linwood A. Starks, D.V.M., due to his inability to practice veterinary medicine in Texas. The decision is based on the registrant's default following a suspension of his state veterinary license, highlighting the importance of state authority in maintaining a DEA registration for handling controlled substances.
Learn More🐾New Animal Drug Regulations Affecting Compliance and Approval Processes
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during October, November, and December 2024. The animal drug regulations are also being amended to improve their accuracy and readability.
Learn More🐾FDA Seeks Input on Cannabis-Derived Products in Veterinary Use
The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with those products, including information about: usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns. This information will enhance the Center for Veterinary Medicine's (CVM's) knowledge of potential safety signals associated with these products, in addition to aiding our understanding of veterinarians' experiences related to the use of CDPs for their animal patients.
Learn More